MetLife, Inc.
New York Stock ExchangeRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- MetLife, Inc. is a global financial services enterprise that delivers insurance solutions, annuities, employee benefits, and asset management expertise across diverse markets worldwide. The company conducts its operations through several key geographic and strategic divisions: the U.S. segment, Asia, Latin America, Europe, the Middle East and Africa (EMEA), and MetLife Holdings. Its extensive portfolio of offerings encompasses various types of protection, including life coverage such as term, whole, universal, and accidental death and dismemberment policies, alongside dental, vision, and pet insurance. MetLife also provides group short-term and long-term disability, individual disability income, and a range of accident and health plans, featuring medical reimbursement, critical illness, and personal accident benefits. For businesses, services include administrative services-only arrangements and prepaid legal plans, in addition to specialized credit insurance products. Within retirement and investment solutions, MetLife offers various annuities, including fixed, variable, deferred, immediate, and indexed-linked options. The company also engages in pension risk transfers, provides institutional income annuities, structures settlements, and offers capital markets investment products. Further offerings extend to financial planning, wealth management, and funding agreements for post-retirement benefits, as well as corporate-owned life insurance for executive benefit programs. Founded in 1868, MetLife, Inc. is headquartered in New York, New York. In late 2024, the company introduced its "New Frontier" growth strategy, aiming to further expand its leadership in Group Benefits, leverage its retirement platforms in the U.S. and Japan, accelerate growth in asset management, and deepen its presence in high-growth international regions like Latin America and Asia. Recent initiatives include a significant longevity swap deal for the BBC Pension Scheme in November 2025 and the continued expansion of its digital platform, MetLife Xcelerator, which reached 4.5 million customers by March 2025. The company's revenue streams are primarily driven by premiums from its insurance and annuity products, investment income from its diverse portfolio, and fees generated from administrative and asset management services.
MetLife Pet Insurance Expands Grief Support for Pet Parents with Memorial Tree Program
MetLife Pet Insurance Expands Grief Support for Pet Parents with Memorial Tree Program
MET – Montreal Metropolitan Airport and YHU Terminal Welcome Their First Passengers
Porter Inaugurates Service at New Montreal Metropolitan Airport (MET)
MetLife Broadens Settlement Solutions Portfolio With NQA-FA
MetLife Launches New Deferred Payment Option for Non-Physical Injury Claims
MetLife Launches New Deferred Payment Option for Non-Physical Injury Claims
MetLife, Inc. (MET) Presents at Morgan Stanley US Financials Conference 2026 Transcript
Lincoln National vs. MetLife: Which Financial Stock Is a Better Buy in 2026?
MetLife: Not Exciting, But It Works
These 3 Insurance Stocks Made New 52-Week Highs: Still Time to Buy?
Dividend Champion, Contender, And Challenger Highlights: Week Of June 7
MetLife Inc (MET) Shares Surge 3.1% -- What GF Score of 77 Tells Investors
MetLife CFO to Speak at Morgan Stanley US Financials Conference
Here's Why Investors Should Stay Neutral on MetLife Stock for Now
RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) pivotal data show strong and durable responses in advanced head and neck cancer where options remain limited
RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) demonstrates prolonged clinical benefit as a first-line treatment for atypical EGFR-mutated non-small cell lung cancer
Ares Marks Eagle Football Debt To 16 Cents As MetLife Pushes Back
MetLife Expands Guaranteed Retirement Income Offering with Innovative Flexible Annuity Option
MetLife: Time To Go Long The Common Shares And 6.35% Yielding Preferreds